Replies to post #81450 on Biotech Values

[DewDiligence]

[exwannabe to BioSpecialist]: This is a generic version of an already marketed drug, fondaparinux. It is NOT the same as heparin. It does not have the same effect.

You are correct, of course. I previously told BioSpecialist to stop posting this misleading message, which he has done repeatedly.

Generic Arixtra, which is what BioSpecialist’s penny-stock company hopes to market, will in all likelihood be a commercial dog because Arixtra itself is a commercial dog (despite its being a good drug from a medical standpoint).